NTCOC
BIO icon

Northern Trust Company of Connecticut’s Bio-Rad Laboratories Class A BIO Stock Holding History

Northern Trust Company of Connecticut’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$433K Sell
3,500
-500
-13% -$60.9K ﹤0.01% 1600
2013
Q3 		$470K Buy
4,000
+500
+14% +$59K ﹤0.01% 1548
2013
Q2 		$393K Buy
+3,500
New +$411K ﹤0.01% 1547

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Company of Connecticut's BIO Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Bio-Rad Laboratories Class A (BIO) stake by 13% in Q4 2013, selling an estimated $60.9K and leaving 3,500 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #1600.

Northern Trust Company of Connecticut first reported a position in BIO in Q2 2013 and has held it in 3 quarters since. The position peaked at $470K in Q3 2013. 198 funds tracked by Wall St. Rank hold BIO as of Q4 2013.

  • Northern Trust Company of Connecticut held 3,500 shares of Bio-Rad Laboratories Class A worth $433K as of Q4 2013.
  • Northern Trust Company of Connecticut sold 500 Bio-Rad Laboratories Class A shares in Q4 2013, an estimated $60.9K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1600 holding.
  • Northern Trust Company of Connecticut first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Bio-Rad Laboratories Class A position peaked at $470K in Q3 2013.
  • 198 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.